Evidence map›Paper›PMID 29784841›Full record

ArticleAntimicrobial agents and chemotherapy2018

Metabolism of Piperaquine to Its Antiplasmodial Metabolites and Their Pharmacokinetic Profiles in Healthy Volunteers.

Huixiang Liu, Hongchang Zhou, Tianyu Cai, Aijuan Yang, Meitong Zang, Jie Xing

Open access · bronzeAbstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 20 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Extended blood stage sensitivity profiles ofAntimicrobial agents and chemotherapy · 2024
    Article
  6. Article
  7. Antimicrobial agents and chemotherapy · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Huixiang Liu *School of Pharmaceutical Sciences, Shandong University, Jinan, China.
Hongchang Zhou *Department of Microbiology, Huzhou University, Huzhou, China.
Tianyu CaiSchool of Pharmaceutical Sciences, Shandong University, Jinan, China.
Aijuan YangSchool of Pharmaceutical Sciences, Shandong University, Jinan, China.
Meitong ZangSchool of Pharmaceutical Sciences, Shandong University, Jinan, China.
Jie XingSchool of Pharmaceutical Sciences, Shandong University, Jinan, China xingjie@sdu.edu.cn.
Shandong University · CNHuzhou University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

As a partner antimalarial for artemisinin drug-based combination therapy (ACT), piperaquine (PQ) can be metabolized into two major metabolites, including piperaquine

Indexed as

AnimalsAntimalarialsArtemisininsBiotransformationDrug Administration ScheduleDrug Dosage CalculationsDrug Therapy, CombinationHalf-LifeHealthy VolunteersHumansMalariaMaleMiceMice, Inbred ICROxidesPiperazinesAntimalarialsartemisininArtemisininsartenimolOxidespiperaquinePiperazinesQuinolinesantiplasmodial activityhealthy subjectsmetabolitepharmacokineticspiperaquine

Identifiers

PMID29784841
PMCPMC6105796
OpenAlexW2804175122

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.